"We succeeded in 'tricking' the virus by giving it part of the free ACE2 receptor [the synthetic peptide], which interacted .

EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology MOSCOW, June 11. /TASS/. Over three mln doses ...

Synthetic long peptide (SLP) vaccines have evolved as a simple solution for the many problems that have surfaced with minimal Tc peptide vaccines. SLP are not able to bind directly to MHC class I ...

Now, researchers in a lab at the University of Minnesota, using a drug called CD200AR-L, have developed their own vaccine to battle brain cancer in kids.

(ABC 6 News) — A new vaccine is being tested in the battle against childhood brain cancer. Researchers at the University of ...

EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology MOSCOW, August 14. /TASS/. No deaths related to ...

Peptide cancer vaccines are designed to stimulate the immune system to recognize and attack cancer cells by presenting specific tumor-associated antigens. These vaccines are primarily categorized into ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

US-based biotech company Vaxxinity has revealed positive data from part B of its Phase I study with its Parkinson’s vaccine UB-312, demonstrating a 20% reduction in toxic protein levels among ...

As such, we can design efficacious functional vaccines that mimic the 3D epitopes. Our first-generation HER-2 peptide vaccines (316–339 and 628–647) were identified prior to the publications ...

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching ...